PROCEPT BioRobotics Corporation
PRCT
Updated: 23/09/2026, 11:08:11
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
No summaries found.
- Share price
- $18.43
- Market cap
- $1.05B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Larry L. Wood
- Employees
- 888
- IPO date
- 15/09/2021
- Beta
- 0.902
- Last dividend
- $0.00
- Day range
- $18.41 – $19.17
- 52-week range
- $16.67 – $39.86
- 1-day performance
- -0.43%
- 1-year performance
- 10.59%
- Current drawdown (1Y)
- -53.76%
- CIK
- 0001588978
- CUSIP
- 74276L105
- ISIN
- US74276L1052
- Created
- 07/12/2025, 13:46:59
- Last update
- 23/09/2026, 11:08:11
Track PROCEPT BioRobotics Corporation with an AI analyst
See which prediction-market events move PRCT, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
PROCEPT BioRobotics Corporation (PRCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 12/05/2026, 22:40:45
PROCEPT BioRobotics Corporation (PRCT) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 30/04/2026, 04:01:33
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Business Wire • STOCK • 22/04/2026, 17:00:00
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
GlobeNewsWire • STOCK • 09/04/2026, 18:05:00
EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH
GlobeNewsWire • STOCK • 23/03/2026, 08:00:00
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
GlobeNewsWire • STOCK • 17/03/2026, 19:05:00
Levi & Korsinsky Investigating Whether PROCEPT BioRobotics Corporation (PRCT) Misled Investors - Securities Law Violations Possible
Newsfile Corp • STOCK • 16/03/2026, 01:27:00
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Business Wire • STOCK • 10/03/2026, 00:26:00
ATTENTION PRCT Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky
Newsfile Corp • STOCK • 09/03/2026, 01:19:00
PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm
Business Wire • STOCK • 08/03/2026, 20:40:00
PROCEPT BioRobotics Corporation (PRCT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Seeking Alpha • STOCK • 06/03/2026, 16:16:00
PRCT: $50.2M ADJUSTED EBITDA LOSS VS. $35M PROJECTED -- LEVI & KORSINSKY, LLP INVESTIGATES
PRNewsWire • STOCK • 04/03/2026, 19:50:00